We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App




Enterovirus D type 111 Genetically and Phenotypically Characterized

By LabMedica International staff writers
Posted on 06 Nov 2019
Members of the species Enterovirus D (EV-D) remain poorly studied. More...
The two first EV-D types (EV-D68 and EV-D70) have regularly caused outbreaks in humans since their discovery five decades ago but have been neglected until the recent occurrence of severe respiratory diseases due to EV-D68.

The three other known EV-D types (EV-D94, EV-D111 and EV-D120) were discovered in the 2000s-2010s in Africa and have never been observed elsewhere. One strain of EV-D111 and all known EV-D120s were detected in stool samples of wild non-human primates, suggesting that these viruses could be zoonotic viruses.

Virologists at the Institut Pasteur (Paris, France) and their international colleagues isolated four EV-D111s that had been in cell cultures from stool samples of children with acute flaccid paralysis in the framework of poliovirus surveillance. Viral RNAs were extracted from cell culture supernatants with the High Pure Viral RNA kit (Roche Diagnostics, Risch-Rotkreuz, Switzerland). Virus genomes were amplified by reverse transcription polymerase chain reaction (RT-PCR) with generic primers and the products were sequenced using Illumina NextSeq HiSeq (Illumina, San Diego, CA, USA).

The acid sensitivity assay was performed on EV-D111 OUP-05-059, using EV-D68 Fermon and EV-D70 J670/71, which are known to be acid-sensitive and acid-resistant, respectively as controls. The ability of EV-D111 OUP-05-059 to produce cytopathic effect in different cell lines was assessed in 96-well plates. To determine whether EV-D111 grows in L cells, L cells were cultivated in 24-well plates until confluence. Anti-CD155 monoclonal antibody were produced and used for immunofluorescence and infectivity inhibition assays.

The team observed that the EV-D111 strains from human samples and the unique simian EV-D111 strain were not phylogenetically distinct, thus suggesting a recent zoonotic transmission. They also discovered evidences of probable intertypic genetic recombination events between EV-D111s and EV-D94s. As recombination can only happen in co-infected cells, this suggests that EV-D94s and EV-D111s share common replication sites in the infected hosts. These sites could be located in the gut since the phenotypic analysis they performed showed that, contrary to EV-D68s and like EV-D94s, EV-D111s are resistant to acid pH.

The scientists also found that EV-D111s induce strong cytopathic effects on L20B cells, a cell line routinely used to specifically detect polioviruses. An active circulation of EV-D111s among humans could then induce a high number of false-positive detection of polioviruses, which could be particularly problematic in Central Africa, where EV-D111 circulates and which is a key region for poliovirus eradication. The authors concluded that their results show that EV-D111s are probably enteric viruses and evolve by exchanging genetic sequences with EV-D94.The study was published on October 17, 2019, in the journal PLOS Neglected Tropical Diseases.

Related Links:
Institut Pasteur
Roche Diagnostics
Illumina



Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
Pipette Calibration System
Artel PCS®
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The approach supports myocardial infarction diagnosis in resource-limited settings by reducing delays between clinical suspicion and biochemical confirmation (Image Credit: Adobe Stock)

Portable Troponin Assay Brings Heart Attack Diagnosis Closer to Patients

Timely confirmation of myocardial infarction often depends on laboratory testing that may not be immediately available at the point of care. This gap between clinical suspicion and definitive evidence... Read more

Molecular Diagnostics

view channel
Image: The platform analyzes cell-free DNA in blood, searching for minute amounts of tumor-derived fragments among background DNA (Image Credit: Adobe Stock)

Blood Test Could Help Fast-Track Lymphoma Diagnosis in Resource-Limited Settings

Lymphoma can be difficult to distinguish from infections and benign conditions, while definitive diagnosis often depends on surgical tissue sampling and specialized pathology that may not be readily available.... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.